샘플 요청 목록

 카트 문의
시장보고서
상품코드
2148039

관절내 점성보충 시장

Viscosupplementation
발행일: | 리서치사: 구분자 Market Glass, Inc. | 페이지 정보: 영문 385 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 7,834,000
PDF & Excel (Team License: Up to 10 users) help
PDF & Excel 보고서를 동일 기업 내 최대 10명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기가 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 이용자 1명당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 11,115 금액 안내 화살표 ￦ 14,886,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 23,504,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 관절내 점성보충 시장은 2032년까지 76억 달러에 달할 전망

2025년에 45억 달러로 추정되는 세계의 관절내 점성보충 시장은 2025년부터 2032년까지의 분석 기간 동안 CAGR 7.7%로 성장하여, 2032년까지 76억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석 대상이 되고 있는 부문 중 하나인 1회 주사용은 CAGR 6.1%를 기록하며 분석 기간 종료까지 29억 달러에 달할 것으로 예상됩니다. 3회 주사용 부문의 성장률은 분석 기간 중 CAGR 9.6%로 추정됩니다.

미국 시장은 12억 달러로 추정되는 한편 중국은 CAGR 11.5%로 성장할 것으로 예측

미국의 관절내 점성보충 시장은 2025년에 12억 달러로 추산됩니다. 세계 2위의 경제 규모를 자랑하는 중국은 2025년부터 2032년까지의 분석 기간 동안 CAGR 11.5%를 기록하며 2032년까지 시장 규모가 17억 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안에 각각 CAGR 4.0% 및 7.3%로 성장할 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 5.0%로 성장할 것으로 예측됩니다.

세계의 관절내 점성보충 시장 - 주요 동향과 촉진요인 정리

왜 관절 내 보충 요법이 퇴행성 관절염의 선호되는 치료법이 되어가고 있는가?

관절 내 보충 요법은 퇴행성 슬관절염(OA)에 대해 널리 채택되고 있는 최소침습 치료법으로 부상하고 있으며, 퇴행성 관절 질환으로 고통받는 환자에게 통증 완화와 관절 가동 범위 개선을 가져다주고 있습니다. 이 시술은 히알루론산(HA)을 활액에 주입하여 관절 내 윤활성을 높이고 마찰을 줄여줍니다. 특히 고령층을 중심으로 퇴행성 관절염의 유병률이 증가하는 가운데, 관절 내 보충 요법은 진통제나 외과적 개입을 대체할 수 있는 선택지로 점점 더 권장되고 있습니다. 또한, 비수술적 통증 관리법에 대한 수요가 높아짐에 따라 정형외과 클리닉이나 병원에서 히알루론산 기반 주사제에 대한 수요가 확대되고 있습니다.

기술 혁신은 관절 내 보충 요법을 어떻게 개선하고 있는가?

관절 내 보충 요법 시장에서는 히알루론산 제제의 개량이 진행되어 치료의 유효성과 지속성이 향상되고 있습니다. 가교형이나 고분자량 히알루론산 주사제 등의 혁신적인 제품 덕분에 관절액의 대체액의 점도와 지속성이 향상되어, 퇴행성 관절염 환자에게 장기적인 통증 완화를 제공하고 있습니다. 또한, 단 한 번의 주사로 끝나는 치료법 개발도 진전되어, 여러 차례의 치료 세션 필요성을 줄이고 환자의 치료 순응도 향상에 기여하고 있습니다. 아울러 각 기업은 치료 효과를 높이고 부작용을 최소화하기 위해 새로운 약물전달 시스템 및 생명공학을 활용한 히알루론산 유도체에 대한 투자도 진행하고 있습니다.

관절 내 보충 요법의 보급을 주도하는 주요 시장 동향은 무엇인가?

조기 개입과 예방 의료에 대한 관심이 높아지고 있는 것이, 퇴행성 슬관절염의 1차 치료법으로서 관절 내 보충 요법의 보급을 뒷받침하고 있습니다. 특히 중장년층과 운동선수들 사이에서 관절 건강과 가동성 유지에 대한 인식이 높아지고 있는 점도 히알루론산 주사에 대한 수요를 더욱 끌어올리고 있습니다. 또한, 히알루론산 주사와 결합한 혈소판 농축 혈장(PRP) 요법 등 재생의학적 접근법의 통합이 진행됨에 따라 관절 내 보충 요법의 치료 범위가 확대되고 있습니다. 퇴행성 관절염 치료에 대한 보험 적용 및 보상 정책도 변화하고 있어, 전 세계 환자들이 관절 내 보충 요법을 더욱 쉽게 이용할 수 있게 되었습니다.

시장 성장을 견인하는 요인은 무엇인가?

관절 내 보충 요법 시장의 성장은 퇴행성 관절염 유병률 증가, 히알루론산(HA) 제제의 발전, 비수술적 통증 관리 솔루션에 대한 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 최소침습 치료로의 전환이 1회 주사형 및 가교형 히알루론산 요법의 채택을 뒷받침하고 있습니다. 또한, 의료 인프라의 개선과 보험 적용 범위 확대로 인해 관절 내 보충 요법이 더욱 널리 이용 가능해지고 있습니다. 재생의료 기술의 통합과 더불어, 퇴행성 관절염의 조기 관리에 대한 환자들의 인식 제고도 시장 확대에 더욱 기여하고 있습니다.

부문 :

투여량(1회 주사용, 3회 주사용, 5회 주사용), 적용 부위(무릎, 고관절, 어깨, 기타), 최종 용도(병원, 외래 수술 센터, 정형외과·스포츠 클리닉, 기타)

주요 기업

  • Allergan PLC
  • Anika Therapeutics SRL
  • Contipro a.s.
  • DePuy Synthes
  • F. Hoffmann-La Roche AG
  • Ferring Pharmaceuticals, Inc.
  • Galderma SA
  • Lifecore Biomedical LLC
  • Merz Aesthetics
  • Mylan Pharmaceutical Pvt. Ltd.
  • Nordic Drugs
  • Sanofi SA
  • Shanghai Jingfeng Pharmaceutical Co., Ltd
  • Smith & Nephew PLC
  • TRB Chemedica International SA

해당 분야의 전문가 관점을 바탕으로 함 - 산업계, 기업, 학계에 걸친 분야 전문가들의 관점을 반영하여, 기존에 발표된 조사 결과 이상의 맥락을 더하고 있습니다.

시장의 초기 신호를 포착 - 기존의 2차 조사에 완전히 반영되기 전에, 전문가 간의 대화, 기업의 동향, 시장과 관련된 논의를 통해 드러나는 변화를 추적합니다.

광범위하고 검증된 정보 기반을 활용 - 컨퍼런스 세션, 기조 연설, 패널 토론, 블로그, 기업 공시 정보, 연차 보고서, 기관지 및 기타 검증된 정보원에서 얻은 인사이트를 통합하고 있습니다.

신호와 전략적 시장 방향성을 연결 - 이러한 관점을 통합하여 시장이 어디로 향하고 있는지, 그 움직임을 주도하는 요인은 무엇인지, 그리고 전략에 있어 가장 중요할 가능성이 있는 동향은 무엇인지 파악합니다.

상세한 기업 정보를 제공 - 시장 수준의 분석에 그치지 않고, 경쟁 환경에 참여하며 그 형성에 기여하고 있는 기업을 면밀히 검토합니다.

주요 지역의 시장 점유율 분석 - 단일 세계 시장 점유율 수치만으로는 전체적인 상황을 파악하기 어렵습니다. 경쟁 구조는 지역에 따라 크게 다를 수 있습니다. 분석상 관련성이 있는 경우, Market Glass의 보고서는 각 시장의 구조와 동향에 맞춰 상세도를 조정하여 주요 지역의 시장 점유율 분석을 심층적으로 다룹니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 26.10.21

Global Viscosupplementation Market to Reach US$7.6 Billion by 2032

The global market for Viscosupplementation estimated at US$4.5 Billion in the year 2025, is expected to reach US$7.6 Billion by 2032, growing at a CAGR of 7.7% over the analysis period 2025-2032. Single Injection Dosage, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Three Injection Dosage segment is estimated at 9.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 11.5% CAGR

The Viscosupplementation market in the U.S. is estimated at US$1.2 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2032 trailing a CAGR of 11.5% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Viscosupplementation Market - Key Trends & Drivers Summarized

Why Is Viscosupplementation Becoming a Preferred Treatment for Osteoarthritis?

Viscosupplementation has emerged as a widely adopted, minimally invasive treatment for knee osteoarthritis (OA), providing pain relief and improved joint mobility for patients suffering from degenerative joint conditions. The procedure involves injecting hyaluronic acid (HA) into the synovial fluid, enhancing lubrication and reducing friction within the joint. With the rising prevalence of osteoarthritis, particularly among the aging population, viscosupplementation is being increasingly recommended as an alternative to pain medication and surgical interventions. Furthermore, the growing preference for non-surgical pain management solutions has led to heightened demand for HA-based injections across orthopedic clinics and hospitals.

How Are Technological Innovations Enhancing Viscosupplementation Therapies?

The viscosupplementation market is witnessing advancements in HA formulation, improving the efficacy and durability of treatment. Innovations such as cross-linked and high-molecular-weight HA injections have enhanced the viscosity and longevity of synovial fluid replacement, providing prolonged pain relief for osteoarthritis patients. Additionally, the development of single-injection therapies is gaining traction, reducing the need for multiple treatment sessions and improving patient compliance. Companies are also investing in novel drug-delivery systems and bioengineered HA derivatives to enhance treatment outcomes and minimize adverse effects.

What Are the Key Market Trends Shaping Viscosupplementation Adoption?

The increasing focus on early intervention and preventive healthcare is driving the adoption of viscosupplementation as a first-line treatment for knee osteoarthritis. Rising awareness about joint health and mobility preservation, especially among middle-aged individuals and athletes, is further fueling demand for HA injections. Additionally, the growing integration of regenerative medicine approaches, such as platelet-rich plasma (PRP) therapy in combination with HA injections, is expanding the therapeutic scope of viscosupplementation. Insurance coverage and reimbursement policies for osteoarthritis treatments are also evolving, making viscosupplementation more accessible to patients worldwide.

What Factors Drive the Growth of the Market?

The growth in the viscosupplementation market is driven by several factors, including the increasing prevalence of osteoarthritis, advancements in HA-based formulations, and the rising demand for non-surgical pain management solutions. The shift towards minimally invasive treatments is propelling the adoption of single-injection and cross-linked HA therapies. Additionally, improvements in healthcare infrastructure and expanding insurance coverage are making viscosupplementation more widely available. The integration of regenerative medicine techniques, coupled with increasing patient awareness of early-stage osteoarthritis management, is further contributing to market expansion.

SCOPE OF STUDY:

The report analyzes the Viscosupplementation market by the following Segments, and Geographic Regions/Countries:

Segments:

Dosage (Single Injection Dosage, Three Injection Dosage, Five Injection Dosage); Application (Knee Application, Hip Application, Shoulder Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Allergan PLC
  • Anika Therapeutics SRL
  • Contipro a.s.
  • DePuy Synthes
  • F. Hoffmann-La Roche AG
  • Ferring Pharmaceuticals, Inc.
  • Galderma SA
  • Lifecore Biomedical LLC
  • Merz Aesthetics
  • Mylan Pharmaceutical Pvt. Ltd.
  • Nordic Drugs
  • Sanofi SA
  • Shanghai Jingfeng Pharmaceutical Co., Ltd
  • Smith & Nephew PLC
  • TRB Chemedica International SA

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Viscosupplementation - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 46 Players Worldwide in 2026 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Osteoarthritis Driving Demand for Viscosupplementation Treatments
    • Growing Preference for Non-invasive and Minimally Invasive Pain Management Solutions
    • Advancements in Hyaluronic Acid Formulations Enhancing Viscosupplementation Efficacy
    • Increasing Adoption of Single-injection Viscosupplements for Patient Convenience
    • Expansion of Orthopedic Clinics and Sports Medicine Practices Boosting Market Growth
    • Surge in Awareness Campaigns Promoting Non-surgical Treatment Alternatives
    • Growing Use of Viscosupplementation in Joint Preservation and Pain Relief
    • Increasing Focus on Aging Population and Geriatric Healthcare Needs
    • Rising Availability of Customized Viscosupplement Products for Specific Joint Applications
    • Growing R&D Investments in Next-generation Viscosupplements with Longer-lasting Effects
    • Expansion of Direct-to-consumer Marketing and Online Product Availability
    • Increasing Adoption of Biodegradable and Natural Hyaluronic Acid Sources
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Viscosupplementation Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
    • TABLE 2: World Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 3: World Historic Review for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 4: World 13-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Single Injection Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Single Injection Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Single Injection Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Three Injection Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Three Injection Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Three Injection Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Five Injection Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Five Injection Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Five Injection Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Knee Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Knee Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Knee Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Hip Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Hip Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Hip Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Shoulder Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Shoulder Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Shoulder Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 29: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 30: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 31: World 13-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 32: World Recent Past, Current & Future Analysis for Orthopedic & Sports Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 33: World Historic Review for Orthopedic & Sports Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 34: World 13-Year Perspective for Orthopedic & Sports Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 37: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 39: USA Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 40: USA 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 41: USA Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 42: USA Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 43: USA 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 44: USA Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 45: USA Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 46: USA 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 48: Canada Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 49: Canada 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 51: Canada Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 52: Canada 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 54: Canada Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 55: Canada 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • JAPAN
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 57: Japan Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 58: Japan 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 60: Japan Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 61: Japan 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Japan Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 64: Japan 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • CHINA
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 66: China Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 67: China 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 68: China Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 69: China Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 70: China 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 71: China Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 72: China Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 73: China 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • EUROPE
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 75: Europe Historic Review for Viscosupplementation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 76: Europe 13-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 78: Europe Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 79: Europe 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 81: Europe Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 82: Europe 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 84: Europe Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 85: Europe 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • FRANCE
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 87: France Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 88: France 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 89: France Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 90: France Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 91: France 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 92: France Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 93: France Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 94: France 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • GERMANY
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Germany Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 97: Germany 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 99: Germany Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 100: Germany 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 102: Germany Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 103: Germany 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 105: Italy Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 106: Italy 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 108: Italy Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 109: Italy 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 111: Italy Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 112: Italy 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 114: UK Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 115: UK 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 116: UK Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 117: UK Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 118: UK 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 119: UK Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 120: UK Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 121: UK 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 123: Spain Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 124: Spain 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 126: Spain Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 127: Spain 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Spain Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 130: Spain 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 132: Russia Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 133: Russia 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Russia Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 136: Russia 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 138: Russia Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 139: Russia 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 142: Rest of Europe 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 145: Rest of Europe 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 148: Rest of Europe 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Viscosupplementation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 151: Asia-Pacific 13-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 154: Asia-Pacific 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 157: Asia-Pacific 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 160: Asia-Pacific 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 162: Australia Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 163: Australia 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 165: Australia Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 166: Australia 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 168: Australia Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 169: Australia 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • INDIA
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 171: India Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 172: India 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 173: India Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 174: India Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 175: India 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 176: India Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 177: India Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 178: India 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 180: South Korea Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 181: South Korea 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 183: South Korea Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 184: South Korea 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 186: South Korea Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 187: South Korea 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 198: Latin America Historic Review for Viscosupplementation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 199: Latin America 13-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Latin America Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 202: Latin America 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Latin America Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 205: Latin America 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Latin America Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 208: Latin America 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Argentina Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 211: Argentina 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Argentina Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 214: Argentina 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 216: Argentina Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 217: Argentina 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 219: Brazil Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 220: Brazil 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 222: Brazil Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 223: Brazil 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 225: Brazil Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 226: Brazil 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 228: Mexico Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 229: Mexico 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 231: Mexico Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 232: Mexico 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 234: Mexico Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 235: Mexico 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 238: Rest of Latin America 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 241: Rest of Latin America 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 244: Rest of Latin America 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 246: Middle East Historic Review for Viscosupplementation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 247: Middle East 13-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 249: Middle East Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 250: Middle East 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 252: Middle East Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 253: Middle East 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 255: Middle East Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 256: Middle East 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 258: Iran Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 259: Iran 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Iran Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 262: Iran 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 264: Iran Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 265: Iran 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 267: Israel Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 268: Israel 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 270: Israel Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 271: Israel 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 273: Israel Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 274: Israel 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 277: Saudi Arabia 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 280: Saudi Arabia 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 283: Saudi Arabia 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 285: UAE Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 286: UAE 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 288: UAE Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 289: UAE 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 291: UAE Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 292: UAE 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 295: Rest of Middle East 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 298: Rest of Middle East 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 301: Rest of Middle East 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AFRICA
    • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 303: Africa Historic Review for Viscosupplementation by Dosage - Single Injection Dosage, Three Injection Dosage and Five Injection Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 304: Africa 13-Year Perspective for Viscosupplementation by Dosage - Percentage Breakdown of Value Sales for Single Injection Dosage, Three Injection Dosage and Five Injection Dosage for the Years 2020, 2026 & 2032
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 306: Africa Historic Review for Viscosupplementation by Application - Knee Application, Hip Application, Shoulder Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 307: Africa 13-Year Perspective for Viscosupplementation by Application - Percentage Breakdown of Value Sales for Knee Application, Hip Application, Shoulder Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 309: Africa Historic Review for Viscosupplementation by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 310: Africa 13-Year Perspective for Viscosupplementation by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Orthopedic & Sports Clinics End-Use and Other End-Uses for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기